Glenview Trust co Has $10.71 Million Stock Holdings in Humana Inc. $HUM

Key Points

• Glenview Trust Co increased its stake in Humana Inc. by 9.1%, holding 40,478 shares worth $10.71 million after purchasing additional shares in the first quarter.
• Several analysts have made adjustments to their ratings and target prices for Humana, with the consensus rating being "Hold" and an average price target of $289.24.
• Humana reported a quarterly revenue of $32.39 billion with earnings per share of $6.27, missing analysts' estimates but showing a 9.6% revenue increase compared to the previous year.

Glenview Trust co grew its position in Humana Inc. (NYSE:HUM - Free Report) by 9.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 40,478 shares of the insurance provider's stock after purchasing an additional 3,368 shares during the period. Glenview Trust co's holdings in Humana were worth $10,710,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the company. Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after buying an additional 46 shares during the period. Applied Finance Capital Management LLC boosted its holdings in shares of Humana by 1.7% during the 1st quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after buying an additional 48 shares during the period. Achmea Investment Management B.V. boosted its holdings in shares of Humana by 0.5% during the 1st quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after buying an additional 49 shares during the period. Beech Hill Advisors Inc. boosted its holdings in shares of Humana by 6.1% during the 1st quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after buying an additional 50 shares during the period. Finally, Townsquare Capital LLC boosted its holdings in shares of Humana by 2.8% during the 1st quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after buying an additional 61 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Truist Financial reduced their target price on shares of Humana from $280.00 to $260.00 and set a "hold" rating for the company in a report on Wednesday, July 16th. Morgan Stanley cut their price objective on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a report on Thursday, July 31st. Wall Street Zen downgraded shares of Humana from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Bank of America boosted their price objective on shares of Humana from $285.00 to $312.00 and gave the company a "neutral" rating in a report on Tuesday, September 2nd. Finally, Wells Fargo & Company cut their price objective on shares of Humana from $348.00 to $344.00 and set an "overweight" rating for the company in a report on Thursday, August 14th. Seven analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $289.24.

Humana Price Performance

HUM stock opened at $271.95 on Wednesday. The company has a 50 day simple moving average of $263.18 and a 200 day simple moving average of $256.79. The stock has a market cap of $32.71 billion, a price-to-earnings ratio of 20.87, a P/E/G ratio of 1.82 and a beta of 0.44. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $348.24. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95.

Humana (NYSE:HUM - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts anticipate that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be given a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.3%. The ex-dividend date is Friday, September 26th. Humana's dividend payout ratio is currently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.